Skip Navigation
Skip to contents
Filter

ARTICLE TYPE

PUBLICATION DATE

10 results
Display

Characteristics of Synchronous Cancers in Gastric Cancer Patients

Bae JS, Lee JH, Ryu KW, Kim YW, Bae JM

  • KMID: 2166089
  • Cancer Res Treat.
  • 2006 Feb;38(1):25-29.
PURPOSE: The primary objective of the current study was to investigate the characteristics of synchronous cancers in gastric cancer patients. MATERIALS AND METHODS: We analyzed the 2,237 patients who were...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Tissue Array Methods for High-throughput Clinicopathologic Research

Lee HS, Kim WH

  • KMID: 2166085
  • Cancer Res Treat.
  • 2006 Feb;38(1):1-6.
Recent research in molecular biology has identified a significant number of novel markers, which may have diagnostic, prognostic and therapeutic significance. High-throughput tissue array method facilitates the validation of novel...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Serum HER2 as a Response Indicator to Various Chemotherapeutic Agents in Tissue HER2 Positive Metastatic Breast Cancer

Kong SY, Lee DH, Lee ES, Park S, Lee KS, Ro J

  • KMID: 2166091
  • Cancer Res Treat.
  • 2006 Feb;38(1):35-39.
PURPOSE: The aim of study was to evaluate the usefulness of serum HER2 as a therapeutic response indicator in patients with HER2 positive metastatic breast cancer (MBC). MATERIALS AND METHODS:...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Increased ERCC Expression Correlates with Improved Outcome of Patients Treated with Cisplatin as an Adjuvant Therapy for Curatively Resected Gastric Cancer

Baek SK, Kim SY, Lee JJ, Kim YW, Yoon HJ, Cho KS

  • KMID: 2166088
  • Cancer Res Treat.
  • 2006 Feb;38(1):19-24.
PURPOSE: It has been reported that the overexpression of the excision repair cross-complementing 1 (ERCC1) gene, which is essential for the repair of cisplatin (CDDP)- DNA adducts, negatively influences the...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Long Term Trends and the Future Gastric Cancer Mortality in Korea : 1983~2013

Choi Y, Gwack J, Kim Y, Bae J, Jun JK, Ko KP, Yoo KY

  • KMID: 2166086
  • Cancer Res Treat.
  • 2006 Feb;38(1):7-12.
PURPOSE: In spite of gastric cancer's decreasing incidence and mortality rates, it is still the most common cancer in Korea. In the present study, we examined the temporal trends of...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Resveratrol at High Doses Acts as an Apoptotic Inducer in Endothelial Cells

In K, Park J, Park H

  • KMID: 2166093
  • Cancer Res Treat.
  • 2006 Feb;38(1):48-53.
PURPOSES: Resveratrol is a phenolic compound found in grapes and other food products. In order to assess the availability of resveratrol as an angio-inhibiting drug, we examined whether resveratrol plays...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Prognostic Factors for Advanced Gastric Cancer: Stage- stratified Analysis of Patients who Underwent Curative Resection

Park JM, Ryu WS, Kim JH, Park SS, Kim SJ, Kim CS, Mok YJ

  • KMID: 2166087
  • Cancer Res Treat.
  • 2006 Feb;38(1):13-18.
PURPOSE: Advanced gastric cancer patients have a poorer prognosis as compared to the patients with early gastric cancer. This study was conducted to define the prognostic factors for advanced gastric...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Arsenic Trioxide Induces A poptosis in Human Colorectal Adenocarcinoma HT-29 Cells Through ROS

Cha Y, Park DW, Lee CH, Baek SH, Kim SY, Kim JR, Kim JH

  • KMID: 2166094
  • Cancer Res Treat.
  • 2006 Feb;38(1):54-60.
PURPOSE: Treatment with arsenic trioxide (As2O3) results in a wide range of cellular effects that includes induction of apoptosis, inhibition of cell growth, promotion or inhibition of cellular differentiation, and...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Optimal Timing for the Administration of Capecitabine with Preoperative Chemoradiation for Locally Advanced Rectal Cancer

Noh YJ, Choi WS, Kim JH, Kim JC, Yu CS, Kim HC, Kim TW, Chang HM, Ryu MH, Ahn SD, Lee SW, Shin SS, Lee JE, Choi EK

  • KMID: 2166090
  • Cancer Res Treat.
  • 2006 Feb;38(1):30-34.
PURPOSE: Capecitabine is an oral fluoropyrimidine carbamate and it is known as an effective radiosensitizer. Capecitabine and its metabolite reach their peak concentration in the plasma at 1~2 hours after...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
The Effect of Simulation on Recurrence after Breast-Conserving Surgery and Radiotherapy : Preliminary Results

Kim JY, Kim YS, Ryu MR, Kim SW, Kay CS, Yoon SC, Park WC, Song BJ, Oh SJ, Jung SS, Won JM, Kim SN, Chung SM

  • KMID: 2166092
  • Cancer Res Treat.
  • 2006 Feb;38(1):40-47.
PURPOSE: To evaluate the effect of the simulation method on recurrence among the patients who received radiotherapy after breast-conserving surgery (BCS) for early breast carcinoma. METHODS AND MATERIALS: Between 1995 and...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close

Go to Top

Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr